| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 677.94 | 653.39 | 662.35 | 669.97 |
| Cash Equivalents | 6.54 | - | - | - |
| Other Liabilities Total | 52.59 | 56.77 | 59.17 | 34.90 |
| Accrued Expenses | 1.53 | 7.39 | 1.11 | 0.68 |
| Long Term Debt | 89.96 | 133.37 | 181.77 | 184.81 |
| Common Stock Total | 8.51 | 8.51 | 8.51 | 8.51 |
| Other Current Assets Total | 13.08 | 14.89 | 15.99 | 15.58 |
| Total Assets | 677.94 | 653.39 | 662.35 | 669.97 |
| Current Portof LT Debt/ Capital Leases | 98.52 | 44.83 | 25.92 | 24.82 |
| Total Equity | 360.24 | 314.26 | 291.79 | 279.73 |
| Long Term Investments | 44.86 | 34.05 | 29.93 | 25.31 |
| Retained Earnings( Accumulated Deficit) | 351.73 | 284.57 | 262.57 | 250.52 |
| Total Common Shares Outstanding | 0.85 | 0.85 | 0.85 | 0.85 |
| Tangible Book Valueper Share Common Eq | 412.04 | 361.59 | 338.39 | 325.38 |
| Total Liabilities | 317.71 | 339.13 | 370.55 | 390.24 |
| Total Debt | 194.79 | 213.25 | 244.38 | 274.15 |
| Short Term Investments | 20.95 | - | - | - |
| Cashand Short Term Investments | 27.49 | 5.59 | 12.31 | 12.67 |
| Total Receivables Net | 95.46 | 96.51 | 102.72 | 103.75 |
| Deferred Income Tax | 8.81 | 5.93 | 7.41 | 7.35 |
| Accounts Receivable- Trade Net | 95.36 | 77.83 | 82.08 | 83.06 |
| Property/ Plant/ Equipment Total- Net | 411.06 | 409.35 | 407.58 | 405.04 |
| Minority Interest | 7.55 | 12.40 | 11.08 | 8.82 |
| Total Current Liabilities | 152.48 | 125.18 | 105.79 | 148.70 |
| Total Inventory | 72.53 | 76.51 | 82.34 | 94.31 |
| Accounts Payable | 24.68 | 29.42 | 26.44 | 29.98 |
| Other Currentliabilities Total | 27.75 | 13.97 | 20.97 | 34.36 |
| Total Long Term Debt | 96.28 | 138.84 | 187.11 | 190.48 |
| Intangibles Net | 9.72 | 6.66 | 3.93 | 2.94 |
| Other Long Term Assets Total | 3.73 | 5.58 | 3.79 | 4.58 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 208.56 | 195.17 | 214.62 | 227.59 |
| Capital Lease Obligations | 6.31 | 5.48 | 5.34 | 5.67 |
| Accumulated Depreciation Total | - | -156.10 | -140.69 | -125.34 |
| Other Equity Total | - | 3.67 | 3.21 | 3.19 |
| Prepaid Expenses | - | 1.68 | 1.27 | 1.28 |
| Additional Paid- In Capital | - | 17.51 | 17.51 | 17.51 |
| Cash | - | 5.59 | 12.31 | 12.67 |
| Property/ Plant/ Equipment Total- Gross | - | 388.78 | 380.16 | 384.25 |
| Notes Payable/ Short Term Debt | - | 29.58 | 31.35 | 58.86 |
| Note Receivable- Long Term | - | 2.57 | 2.50 | 4.51 |
Hester Biosciences Dividend Hester Biosciences Bonus Hester Biosciences News Hester Biosciences AGM Hester Biosciences Rights Hester Biosciences Splits Hester Biosciences Board Meetings Hester Biosciences Key Metrics Hester Biosciences Shareholdings Hester Biosciences Profit Loss Hester Biosciences Cashflow Hester Biosciences Q1 Results Hester Biosciences Q2 Results Hester Biosciences Q3 Results Hester Biosciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.